Prelude Therapeutics (PRLD) Cash & Equivalents Growth (1y) (2020 - 2026)
Prelude Therapeutics (PRLD) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
988.88% |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
91.37% |
| Date | Value |
|---|
| Mar 31, 2026 |
91.37% |
| Dec 31, 2025 |
113.44% |
| Sep 30, 2025 |
234.48% |
| Jun 30, 2025 |
142.53% |
| Mar 31, 2025 |
54.13% |
| Dec 31, 2024 |
-43.69% |
| Sep 30, 2024 |
-23.88% |
| Jun 30, 2024 |
4.53% |
| Mar 31, 2024 |
29.25% |
| Dec 31, 2023 |
-15.34% |
| Sep 30, 2023 |
-64.43% |
| Jun 30, 2023 |
-44.31% |
| Mar 31, 2023 |
-60.05% |
| Dec 31, 2022 |
-3.41% |
| Sep 30, 2022 |
-8.72% |
| Jun 30, 2022 |
-84.04% |
| Mar 31, 2022 |
-84.66% |
| Dec 31, 2021 |
-83.57% |
| Sep 30, 2021 |
-73.84% |
| Dec 31, 2020 |
1,056.36% |
